Initial Dose of Diuretics for Heart Failure Admissions Matters
Does initial dosing of diuretics for heart failure admissions change length of stay (LOS) or have any bearing on outcomes?
Does initial dosing of diuretics for heart failure admissions change length of stay (LOS) or have any bearing on outcomes?
Is oral anticoagulant monotherapy safer and more effective than dual antithrombotic therapy in patients with atrial fibrillation (AF), coronary artery disease (CAD), and advanced chronic kidney disease (CKD)?
Do SGLT2 inhibitors need to be discontinued in patients with type 2 diabetes mellitus (T2DM) who develop a urinary tract infection (UTI), and what are the clinical implications after discontinuation?
Among patients with atrial fibrillation (AF) receiving apixaban or rivaroxaban, does concomitant use of diltiazem increase the risk of serious bleeding compared with metoprolol for rate control?
Does proton pump inhibitor (PPI) use increase the risk of obstructive lung disease exacerbation?
Does ultrasound-facilitated, catheter-directed thrombolysis improve clinical outcomes in patients with acute pulmonary embolism (PE), right ventricular strain, and signs of cardiorespiratory distress?
Can GLP-1 receptor agonists be used to reduce alcohol use in obese patients motivated to reduce alcohol consumption?
The arrival and continued expansion of SpaceXAI in Memphis presents our city with an extraordinary opportunity and an equally important responsibility.